Call to Schedule Free Consultation at Over 80 Centers Worldwide!

(844) GET-STEM

Stage 4 Liver Disease Reversed: A Stem Cell Therapy Patient Story

Written by Dr. David Greene, MD, PhD, MBA on June 2, 2026

Table of Contents

For millions of Americans managing diabetes, the disease rarely travels alone. Over time, it damages nerves, organs, and tissues in ways that standard medications can slow but often cannot reverse. For Steve Merritt, that reality had become life-threatening — until stem cell therapy changed the trajectory.

This article shares Steve and Bonnie’s story, places it within the current scientific understanding of stem cell therapy for metabolic and liver conditions, and helps patients understand what this type of treatment may — and may not — offer.

Steve's Medical Background: A Complex, Progressive Case

Steve had lived with uncontrolled diabetes for many years. By the time his wife Bonnie became involved in managing his care, he had already developed stage 4 diabetic gastroparesis — severe delayed stomach emptying caused by diabetes-related nerve damage — requiring hospitalizations and surgery.

Then came a second diagnosis that changed everything.

“He had stage four fatty liver disease — cirrhosis of the liver,” Bonnie recalled. “I was told he probably had less than two years to live.”

Facing that prognosis, Bonnie turned to regenerative medicine, specifically stem cell therapy, having researched its potential for liver and metabolic conditions.

What Happened After Treatment

Steve received stem cell treatments in May and June. By the following January — roughly eight months later — his medical tests produced results that surprised even his physicians.

Gastroparesis: Gone. Despite being told stage 4 gastroparesis was not reversible, follow-up testing showed complete resolution.

Fatty liver disease: Steve moved from stage 4 to stage 2 — a two-stage improvement in a condition his doctors described as irreversible.

Medications: His insulin was cut nearly in half. One blood pressure medication was eliminated, one was reduced by 75%, and another by 50%.

Daily function: Steve went from barely completing a workday to fishing with his grandson, staying mentally sharp, and performing better professionally as an attorney.

“I feel like a person again who can enjoy life,” Steve said. “I feel a lot mentally sharper than I did before stem cell therapy.”

What Does the Science Say?

Stem Cells and Fatty Liver Disease

Research into mesenchymal stem cells (MSCs) for liver conditions is an active and growing field. Studies published in journals including Cell Transplantation and World Journal of Gastroenterology have examined MSC therapy’s ability to reduce liver fibrosis and inflammation. While large-scale clinical trials are still ongoing, early evidence suggests MSCs may support liver regeneration by reducing inflammatory cytokines and stimulating tissue repair. Steve’s reported improvement from stage 4 to stage 2 is consistent with outcomes being investigated in this research.

Stem Cells and Diabetic Gastroparesis

Gastroparesis linked to diabetes involves damage to the vagus nerve and the interstitial cells of Cajal — the pacemaker cells of the gut. Preclinical studies have explored stem cell therapy’s potential to repair this nerve damage. While human clinical evidence remains limited, case-level reports like Steve’s provide important signals that warrant further study.

Stem Cells and Blood Sugar Control

Multiple studies have examined MSC therapy’s effect on insulin sensitivity and pancreatic function in type 2 diabetes. A 2018 review in Stem Cell Research & Therapy noted that MSC infusions were associated with improved glycemic control in several pilot trials. Steve’s significant insulin reduction aligns with this emerging evidence.

Important Considerations for Patients

Results like Steve’s are compelling, but patients should approach stem cell therapy with informed expectations:

Individual outcomes vary. Not every patient will experience the same degree of improvement.

This is not a replacement for medical care. Stem cell therapy works best alongside — not instead of — conventional treatment and physician monitoring.

Choose a reputable provider. Ensure the clinic follows regulatory guidelines and offers transparent information about the cells being used.

R3 Stem Cell works with licensed physicians and uses FDA-compliant biologics. Their team can help patients understand whether their condition may be appropriate for regenerative treatment. Patients with diabetes-related complications may find it particularly useful to review how stem cell therapy works for conditions like neuropathy and cardiovascular disease.

Quality of Life: The Measure That Matters Most

Beyond the lab numbers, Steve’s story is ultimately about getting his life back. He fishes with his grandson. He shows up fully at work. He and Bonnie expect more years together with their children and grandchildren.

“You cannot put a price on that,” Bonnie said, “and you can’t put a price on health.”

For patients and families facing serious, progressive chronic illness, that perspective is worth holding onto — alongside honest, evidence-informed conversations with a qualified physician about whether regenerative medicine belongs in the care plan.

To learn more or schedule a consultation, visit R3 Stem Cell or explore the cost of stem cell therapy and financing options available.

Contact Us

Stem cell therapy for diabetes is not yet a standard of care in most countries and is generally considered investigational or complementary. Patients should review FDA regulations on cell therapies for context.

The Delivery Process Is Not Changed

Why Dr. Hector is "Passionate" About the Word "Natural"

Consent alone is not sufficient. Donor mothers also undergo comprehensive medical screening, which typically includes:

What Does the Bioethics Community Say?